Financial Performance - For the quarter ended December 2024, Tandem Diabetes Care, Inc. reported revenue of 252.45million,reflectinga28.30.44, compared to -0.27inthesamequarterlastyear,indicatingadecline[1]−ThereportedrevenuewasslightlybelowtheZacksConsensusEstimateof255.18 million, resulting in a revenue surprise of -1.07% [1] - The company experienced an EPS surprise of -76.00%, with the consensus EPS estimate being -0.25[1]KeyMetrics−SharesofTandemDiabetesCarehavereturned−8.4214.56 million, exceeding the average estimate of 190.90millionbythreeanalysts,representingayear−over−yearincreaseof42.268.09 million, significantly surpassing the average estimate of 59.87million,withayear−over−yearchangeof148291.598.44 million, slightly below the average estimate of 101.47million,markinga19.585.92 million, compared to the average estimate of 89.43million,reflectinga625.77 million, exceeding the average estimate of 19.85million,withayear−over−yearincreaseof47.242.32 million, surpassing the average estimate of 40.50million,indicatinga14.9128.24 million, slightly below the average estimate of 128.87million[4]−Revenuefrompumpswasreportedat124.21 million, exceeding the average estimate of $121.53 million [4]